| Novo Nordisk B A/S | 514.50 / -0.08% |
| Date/Time | 06/18 / 16:59 |
| Chg. / Chg.(%) | -0.40 / -0.08% |
| Bid | 514.50 / 658 |
| Ask | 514.90 / 1503 |
| Open | 513.10 |
| Previous Close | 514.90 |
| High | 518.90 |
| Low | 512.90 |
| Volume [DKK] | 1,518,607,515.40 |
| Volume [Units] | 2,997,574 |
| Price fixings | 13326 |
| ISIN | DK0060534915 |
| Security | NOVO/B |
| Exchange | OMX Nordic |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 69.13 |  |
|
| OMX Nordic | 514.50 | |
2,997,574 |
| Cboe Europe .. | 514.80 | |
886,737 |
| London Inter.. | 514.05 | |
491,053 |
| Turquoise | 514.60 | |
171,013 |
| TradeGate | 69.26 | |
6,924 |
| Xetra | 69.20 | |
4,744 |
| Frankfurt | 69.0200 | |
4,248 |
| Nasdaq Other.. | 79.8800 |  |
1,119 |
| Stuttgart | 69.140 | |
933 |
| Cboe Europe .. | 514.40 | |
822 |
| gettex | 69.250 | |
650 |
| Vienna Globa.. | 69.14 | |
619 |
| Cboe Europe .. | 514.85 | |
526 |
| Hamburg | 69.15 | |
90 |
| Quotrix | 69.1600 | |
47 |
| Cboe Europe .. | 69.10 | |
34 |
| Düsseldorf | 69.08 | |
0 |
| Berlin | 69.38 | |
0 |
| München | 69.22 | |
0 |
| Hannover | 69.22 | |
0 |
News
- Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy
06/16/2021 / 07:00 - GlobeNewswire - Creo Appoints Industry Leader Joel Cherry as Chief Technology Officer
06/15/2021 / 13:05 - GlobeNewswire - Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021
06/14/2021 / 07:00 - GlobeNewswire - Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting
06/10/2021 / 07:00 - GlobeNewswire - New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
06/09/2021 / 12:00 - GlobeNewswire
Real-time